Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online pharmacies say, in a sign the U.S. drugmaker is gaining ground on its ...
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
open image in gallery An injection pen of Zepbound, Eli Lilly’s weight loss drug, is seen next to boxes of Novo Nordisk’s Wegovy earlier this year. Novo Nordisk said it would wait for the ...
Novo Nordisk announced today that Wegovy® (semaglutide injection) is now approved to reduce the risk of non-fatal myocardial ...
The most commonly reported adverse events in SURMOUNT-5 for both Zepbound and Wegovy were gastrointestinal ... indigestion, injection site reactions, feeling tired, allergic reactions, belching ...
i At 72 weeks, Zepbound beat Wegovy on both the primary endpoint ... pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, hair loss, and heartburn.
Zepbound® (tirzepatide) provided a 47% greater relative weight loss compared to Wegovy&circledR ... pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback